Skip to main content

REVIEW article

Front. Cardiovasc. Med.
Sec. Cardiac Rhythmology
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1449028

Stereotactic Arrhythmia Radioablation (STAR) opens a new era in the treatment of arrhythmias?

Provisionally accepted
Shuang Zhang Shuang Zhang Lin Hu Lin Hu Hanze Tang Hanze Tang *Liyi Liao Liyi Liao *Xuping Li Xuping Li *
  • Second Xiangya Hospital, Central South University, Changsha, China

The final, formatted version of the article will be published soon.

    Tachyarrhythmias are common cardiovascular emergencies encountered in clinical practice. Among these, atrial fibrillation (AF) and ventricular tachycardia (VT) pose significant hazards due to their prevalence and severity. Initially, non-invasive pharmacological antiarrhythmic interventions were the primary treatment modality; however, due to their limited control rates and side effects, invasive therapies have been introduced in recent years. These include catheter ablation, alcohol ablation, cardiac implantable electronic devices, and heart transplantation. Nonetheless, for some patients, invasive treatments do not offer a definitive cure for arrhythmias and carry the risk of recurrence, especially with AF and VT, where the relapse rates are high and the treatment for VT is correlated with the type of tachycardia present.Currently, novel non-invasive treatment methods are emerging, with stereotactic radioablation therapy becoming an effective alternative for the management of refractory tachyarrhythmias. This review provides an overview of the application background of Stereotactic Arrhythmia Radioablation (STAR) therapy and promising results from its use in animal models and clinical applications.Cardiovascular diseases are the leading cause of death globally. It is estimated that about 17.9 million people die from cardiovascular diseases each year, accounting for 31% of all global deaths

    Keywords: stereotactic arrhythmia radioablation (STAR), Arrhythima, ventriculair arrhythmia, atrial fibrilation (AF), noninvasive treatment

    Received: 14 Jun 2024; Accepted: 10 Sep 2024.

    Copyright: © 2024 Zhang, Hu, Tang, Liao and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Hanze Tang, Second Xiangya Hospital, Central South University, Changsha, China
    Liyi Liao, Second Xiangya Hospital, Central South University, Changsha, China
    Xuping Li, Second Xiangya Hospital, Central South University, Changsha, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.